CMOS: advanced and beyond
Discover why imec is the premier R&D center for advanced logic & memory devices.
Connected health solutions
Explore the technologies that will power tomorrow’s wearable, implantable, ingestible and non-contact devices.
Life sciences
See how imec brings the power of chip technology to the world of healthcare.
Sensor solutions for IoT
Dive into innovative solutions for sensor networks, high speed networks and sensor technologies.
Artificial intelligence
Explore the possibilities and technologies of AI.
More expertises
Discover all our expertises.
Be the first to reap the benefits of imec’s research by joining one of our programs or starting an exclusive bilateral collaboration.
Build on our expertise for the design, prototyping and low-volume manufacturing of your innovative nanotech components and products.
Use one of imec’s mature technologies for groundbreaking applications across a multitude of industries such as healthcare, agriculture and Industry 4.0.
Venturing and startups
Kick-start your business. Launch or expand your tech company by drawing on the funds and knowhow of imec’s ecosystem of tailored venturing support.

The Kidney Implant Development Network Worldwide (KIDNEW) is a cooperative effort, pulled by Fokko Wieringa (imec & Dutch Kidney Foundation) and Murray Sheldon (FDA-CDRH) to stimulate communication and cooperation between the best brains in the world on better Kidney Replacement Therapies, ultimately aiming for an Implantable Artificial Kidney (IAK).


Group picture at the 2nd KIDNEW meeting, during ASN 2019.

What does KIDNEW do?

  • It targets the support of disruptive KRT solutions that can fundamentally improve the quality of life for people with kidney failure. It strives for their worldwide availability and affordability.
  • It promotes the synchronization between roadmaps from the Kidney Health Initiative (KHI), European Kidney Health Alliance (EKHA)  & International Society of Nephrology (ISN). And it directly interacts between relevant international scientists, engineers, physicians, patients, policy makers, investors, regulators, foundations & other stakeholders (all interacting at IDEAS) to boost the development of an (ultimately) implantable artificial kidney.
  • It expresses no preferences about the exact form of the resulting product(s), like technical device, bioreactor, xenotransplant, chimera, or others.


News about KIDNEW

On World Kidney Day, March 11 2021, US and EU kidney groups set up a new collaboration to expand the role of kidney patients as central influencers to drive innovation in kidney therapies. Read the press release